Sunshine Biopharma News

8-K: Current report

Sep 10 16:09 ET

8-K: SUNSHINE BIOPHARMA REPORTS 2024 SECOND QUARTER RESULTS: SECOND QTR REVENUES UP 67%, YTD REVENUES UP 61%

Aug 19 16:09 ET

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Aug 14 16:12 ET

8-K: Current report

Aug 12 16:06 ET

DEF 14C: Definitive information statements

Jul 11 16:04 ET

8-K: Current report

Jul 2 16:11 ET

8-K: Current report

Jul 1 16:12 ET

8-K: Current report

Jun 11 16:03 ET

8-K: Current report

Jun 7 16:03 ET

8-K: SUNSHINE BIOPHARMA REPORTS 2024 FIRST QUARTER RESULTS: REVENUES UP 54%

May 22 16:16 ET

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

May 15 10:45 ET

8-K: Current report

May 8 16:28 ET

8-K: Current report

May 6 12:19 ET

8-K: Current report

Apr 23 16:11 ET

Sunshine Biopharma | 8-K: Current report

Apr 1 14:32 ET

Sunshine Biopharma | DEF 14C: Definitive information statements

Mar 15 11:16 ET

Sunshine Biopharma | 8-K: Current report

Mar 6 16:12 ET

Sunshine Biopharma | DEF 14C: Definitive information statements

Mar 5 11:40 ET

Sunshine Biopharma | 8-K: Current report

Mar 1 16:25 ET

Sunshine Biopharma | 8-K: Current report

Feb 16 17:03 ET